Hot Topics: Opioid Crisis: Law and Legislation

Code of Federal Regulations (CFR)

Links to:
§ 290bb - Center for Substance Abuse Treatment
§ 290bb-1 - Residential treatment programs for pregnant and postpartum women
§ 290bb-1a - Transferred
§ 290bb-2 - Priority substance abuse treatment needs of regional and national significance
§ 290bb-2a - Medical treatment of narcotics addiction; report to Congress
§ 290bb-3 - Repealed. Pub. L. 106–310, div. B, title XXXIII, § 3301(c)(1)–(3), Oct. 17, 2000, 114 Stat. 1209
§ 290bb-6 - Action by Center for Substance Abuse Treatment and States concerning military facilities
§ 290bb-7 - Substance use disorder treatment and early intervention services for children and adolescents
§ 290bb-8 - Repealed. Pub. L. 114–255, div. B, title IX, § 9017, Dec. 13, 2016, 130 Stat. 1248
§ 290bb-10 - Evidence-based prescription opioid and heroin treatment and interventions demonstration

Summer, 2020 "Opioid litigation continues a growing public health litigation trend in which governments seek to hold companies responsible for population harms related to their products. The litigation can serve to address gaps in regulatory and legislative policymaking and in market self-regulation pervasive in the prescription opioid domain. Moreover, prior opioid settlements have satisfied civil tort litigation objectives of obtaining compensation for injured parties, deterring harmful behavior, and holding certain opioid manufacturers, distributors and pharmacies accountable for their actions. In this way, opioid litigation represents progress over prior public health litigation campaigns involving tobacco, lead paint, and asbestos, which had more limited tort litigation effects. Although opioid litigation is not a comprehensive solution to the opioid crisis, it can complement other strategies and infuse much needed money, behavior changes, and public accountability for prescription opioid and related harms."